Expression of TMPRSS4 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis

Medical Oncology

Volumn 30, Issue 4, 2013, Pages

  Dai, Wei ^a   Zhou, Qing ^a   Xu, Zhongfei ^a   Zhang, Enjiao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Prognosis; Salivary adenoid cystic carcinoma; TMPRSS4; Type II transmembrane serine proteases

Indexed keywords

SERINE PROTEINASE; TRANSMEMBRANE PROTEASE SERINE 4; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; TMPRSS4 PROTEIN, HUMAN;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY ADENOID CYSTIC CARCINOMA; SALIVARY GLAND CARCINOMA; WESTERN BLOTTING; AGED; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SALIVARY GLAND; SALIVARY GLAND TUMOR; SURVIVAL;

ADULT; AGED; CARCINOMA, ADENOID CYSTIC; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; SERINE ENDOPEPTIDASES; SURVIVAL ANALYSIS;

EID: 84891876587     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0749-7     Document Type: Article

References (29)

1. Cai Y, Wang R, Zhao YF, Jia J, Sun ZJ, Chen XM. Expression of Neuropilin-2 in salivary adenoid cystic carcinoma: its implication in tumor progression and angiogenesis. Pathol Res Pract. 2010;206(12):793-9.
2. Tang QL, Chen WL, Tan XY, Li HG, Yuan XP, Fan S, et al. Expression and significance of Cyr61 in distant metastasis cells of human primary salivary adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(2):228-36.
3. Tang Y, Liang X, Zheng M, Zhu Z, Zhu G, Yang J, et al. Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol. 2010;46(4):311-6.
4. Webb SL, Sanders AJ, Mason MD, Jiang WG. Type II transmembrane serine protease (TTSP) deregulation in cancer. Front Biosci (Landmark Ed). 2011;16:539-52.
5. Wallrapp C, Hahnel S, Muller-Pillasch F, Burghardt B, Iwamura T, Ruthenburger M, et al. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res. 2000;60(10):2602-6. (Pubitemid 30318232)
6. Cheng D, Kong H, Li Y. TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer. Int J Mol Sci. 2013;14(7):14659-68.
7. Liang B, Wu M, Bu Y, Zhao A, Xie F. Prognostic value of TMPRSS4 expression in patients with breast cancer. Med Oncol. 2013;30(2):497.
8. Luo ZY, Wang YY, Zhao ZS, Li B, Chen JF. The Expression of TMPRSS4 and Erk1 Correlates with Metastasis and Poor Prognosis in Chinese Patients with Gastric Cancer. PLoS ONE. 2013;8(7):e70311.
9. Larzabal L, Nguewa PA, Pio R, Blanco D, Sanchez B, Rodriguez MJ, et al. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer. 2011;105(10):1608- 14.
10. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg. 2005;242(3):353-61 discussion 61-3.
11. Kim S, Kang HY, Nam EH, Choi MS, Zhao XF, Hong CS, et al. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin α5 and its signaling pathways. Carcinogenesis. 2010;31(4):597-606.
12. Li T, Zeng ZC, Wang L, Qiu SJ, Zhou JW, Zhi XT, et al. Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition. Cancer Gene Ther. 2011;18(9):617-26.
13. Jung H, Lee KP, Park SJ, Park JH, Jang YS, Choi SY, et al. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene. 2008;27(18):2635-47. (Pubitemid 351550879)
14. Dong L, Wang YX, Li SL, Yu GY, Gan YH, Li D, et al. TGF-beta1 promotes migration and invasion of salivary adenoid cystic carcinoma. J Dent Res. 2011;90(6):804-9.
15. Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem. 2011;112(9):2508-17.
16. Zhou CX, Gao Y. Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. Oncol Rep. 2006;16(3):505-11.
17. Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer. 2001;96(3):149-58. (Pubitemid 32520669)
18. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26(2):154-62. (Pubitemid 38160449)
19. Matsuba HM, Thawley SE, Simpson JR, Levine LA, Mauney M. Adenoid cystic carcinoma of major and minor salivary gland origin. Laryngoscope. 1984;94(10):1316-8. (Pubitemid 14007799)
20. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66(1):152-9. (Pubitemid 44175654)
21. Stallmach I, Zenklusen P, Komminoth P, Schmid S, Perren A, Roos M, et al. Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch. 2002;440(1):77-84. (Pubitemid 34143353)
22. Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol. 2002;161(4):1315-23.
23. Netzel-Arnett S, Hooper JD, Szabo R, Madison EL, Quigley JP, Bugge TH, et al. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 2003;22(2-3):237-58. (Pubitemid 36561060)
24. Ohler A, Becker-Pauly C. TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections. Biol Chem. 2012;393(9):907-14.
25. Choi SY, Shin HC, Kim SY, Park YW. Role of TMPRSS4 during cancer progression. Drug News Perspect. 2008;21(8):417-23.
26. Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol. 2005;27(6):1677-83.
27. Jou J, Diehl AM. Epithelial-mesenchymal transitions and hepatocarcinogenesis. J Clin Invest. 2010;120(4):1031-4.
28. Bates RC, Mercurio AM. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther. 2005;4(4):365-70. (Pubitemid 41351251)
29. Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, et al. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS ONE. 2012;7(7):e42048.